Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 116.50
Bid: 115.00
Ask: 118.00
Change: 8.00 (7.37%)
Spread: 3.00 (2.609%)
Open: 108.50
High: 117.50
Low: 107.00
Prev. Close: 108.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of share options to employees

22 Feb 2022 07:02

RNS Number : 3478C
Transense Technologies PLC
22 February 2022
 

 

Transense Technologies plc

("Transense" or "the Company")

 

Grant of share options to employees

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that it has today granted 93,000 options to acquire ordinary shares in the Company to employees. The options have an exercise price of 79.5 pence per share and can be exercised after three years until the tenth anniversary of grant. None of these options were granted to directors, and they carry specific exercise conditions related to the future financial performance of relevant business segments.

In order to create sufficient capacity to grant these options within the current approved limit of 10% of issued share capital, Chief Financial Officer Melvyn Segal has elected to waive 50,000 share options granted to him on 26 June 2017 and which will be cancelled.

Following this announcement, there are now 1,582,000 unexercised share options currently in issue under active Company schemes, representing approximately 9.62% of the current issued share capital of the Company.

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

 

Notes to Editors:

Transense develops and supplies wireless sensor technology and systems. The company has three business areas:

· SAW, patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, that is used to improve efficiency, performance and safety of propulsion systems and machinery;

· Translogik, smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and

· iTrack, a tyre pressure monitoring system for off-highway machinery, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal.

Target market sectors include automotive, aerospace and industrial machinery. The Group's strategy is to leverage excellence in innovation, know-how in wireless sensor technologies and form industry partnerships in these global growth sectors to maximise shareholder value through sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.

 

For further information please contact transense@walbrookpr.com.

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Melvyn Segal

2

 

Reason for the notification

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

Transense Technologies plc

b)

 

LEI

 

2138005N52J6KKQ3EY67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence each

 

 

Identification code

GB00BDHDTH21

 

 

b)

 

Nature of the transaction 

 

Cancellations of options

c)

Price and volume

Price: n/a

 

Volume: 50,000

d)

 

Aggregated information

 

 

 

- Aggregated volume

As above

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

22 February 2022

f)

 

Place of the transaction

 

Outside of a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESEUESFEESESE
Date   Source Headline
26th Jun 20201:54 pmRNSDirector/PDMR Shareholding
26th Jun 20207:00 amRNSGrant of Options/PDMR Dealing
25th Jun 20204:41 pmRNSDirector/PDMR Shareholding
25th Jun 20202:10 pmRNSDirector/PDMR Shareholding
25th Jun 20207:01 amRNSStrategic Update
25th Jun 20207:00 amRNSBridgestone Granted Worldwide iTrack Licence
12th Jun 202010:40 amRNSUpdate relating to the JCA with Bridgestone
1st Jun 20207:00 amRNSUpdate relating to the JCA with Bridgestone
5th May 20202:39 pmRNSHolding(s) in Company
1st May 20207:00 amRNSUpdate relating to the JCA with Bridgestone
16th Mar 20207:00 amRNSFurther Working Capital Loan Agreement
20th Feb 20207:00 amRNSInterim Results
20th Feb 20207:00 amRNSInterim Results
19th Feb 20207:00 amRNSChanges to Board responsibilities
13th Feb 20207:01 amRNSNotice of Interim Results
13th Feb 20207:00 amRNSExtension to Agreement with Bridgestone
19th Dec 20194:14 pmRNSResult of AGM
19th Dec 20197:00 amRNSAGM Statement
19th Nov 20197:00 amRNSNotice of AGM
15th Nov 20194:53 pmRNSHolding(s) in Company
7th Nov 20191:13 pmRNSHolding(s) in Company
26th Sep 20197:00 amRNSFinal results for the year ended 30 June 2019
14th Aug 20199:09 amRNSHolding(s) in Company
13th Aug 20192:45 pmRNSAwards of Options
13th Aug 20197:00 amRNSJoint Collaboration Agreement with Bridgestone
30th Jul 20197:00 amRNSTrading Update
1st Jul 201912:02 pmRNSHolding(s) in Company
30th Apr 20194:10 pmRNSHolding(s) in Company
29th Apr 20198:52 amRNSHolding(s) in Company
26th Apr 20191:42 pmRNSHolding(s) in Company
4th Apr 201910:31 amRNSHolding(s) in Company
1st Apr 20193:02 pmRNSResult of General Meeting
22nd Mar 201910:30 amRNSHolding(s) in Company
20th Mar 201910:02 amRNSHolding(s) in Company
15th Mar 20199:33 amRNSNotice of GM and Posting of Circular
14th Mar 20193:30 pmRNSEIS Advance Assurance and Total Voting Rights
13th Mar 20193:35 pmRNSPlacing & General Meeting
13th Mar 20193:35 pmRNSInterim Results
22nd Feb 20198:36 amRNSHolding(s) in Company
20th Feb 20198:30 amRNSiTrack Contract Win
18th Feb 20197:00 amRNSSignificant iTrack Order
4th Feb 20197:00 amRNSGE Aviation Contract Win
21st Dec 20181:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSAGM Statement
21st Nov 20187:00 amRNSNotice of AGM
12th Nov 20187:00 amRNSTranslogik iTrack Contract Win in new Territory
9th Oct 20187:00 amRNSFinal Results
26th Sep 20187:00 amRNSNotice of Results
23rd Aug 20182:44 pmRNSHolding(s) in Company
1st Aug 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.